McKesson Net Change in Investments - Total 2010-2025 | MCK
McKesson annual/quarterly net change in investments - total history and growth rate from 2010 to 2025. Net change in investments - total can be defined as the total change in long term and short term investments
- McKesson net change in investments - total for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
- McKesson net change in investments - total for the twelve months ending March 31, 2025 was $0M, a 0% increase year-over-year.
- McKesson annual net change in investments - total for 2025 was $0B, a 0% decline from 2024.
- McKesson annual net change in investments - total for 2024 was $0B, a 0% decline from 2023.
- McKesson annual net change in investments - total for 2023 was $0B, a 0% decline from 2022.
McKesson Annual Net Change in Investments - Total
(Millions of US $) |
| 2025 |
$N/A |
| 2024 |
$N/A |
| 2023 |
$N/A |
| 2022 |
$N/A |
| 2021 |
$N/A |
| 2020 |
$N/A |
| 2019 |
$N/A |
| 2018 |
$N/A |
| 2017 |
$N/A |
| 2016 |
$N/A |
| 2015 |
$N/A |
| 2014 |
$N/A |
| 2013 |
$N/A |
| 2012 |
$N/A |
| 2011 |
$N/A |
| 2010 |
$N/A |
| 2009 |
$N/A |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$86.050B |
$359.051B |
|
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
|
